ALEC
Alector, Inc.
Biotechnology · Healthcare · United States
2.21
close · 2026-10-30
value
6
cheaper than peers6
quality
3
stronger fundamentals3
ranked against
Biotechnology (commercial)
value
quality
162 peerswide variation
Value inputs
| measure | company | vs peers |
| cash flow yield, 3 years ago | -9.9% | 45 |
| price to sales | 17.80× | 39 |
| earnings yield, 3 years ago | -73.3% | 24 |
| earnings yield, 2 years ago | -70.6% | 23 |
| earnings yield, 1 year ago | -55.7% | 22 |
| earnings yield, latest year | -62.9% | 17 |
| cash flow yield, 2 years ago | -75.6% | 13 |
| cash flow yield, latest year | -74.6% | 12 |
| cash flow yield, 1 year ago | -93.7% | 9 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | -734.7% | 26 |
| revenue growth | -57.8% | 18 |
| return on equity | -385.1% | 5 |
3 of 4 measures available
Facts
| market cap | $247M |
| free cash flow | -$107.3M |
| employees | 103 |
| first trade | 2019-02-07 |
| next earnings | not reported |
| fundamentals updated | 2026-08-13 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -1.39 | -1.23 | -1.56 | -1.62 |
| free cash flow | -$184.1M | -$231.2M | -$186.5M | -$24.4M |
| net income | -$142.9M | -$119.0M | -$130.4M | -$133.3M |
| revenue | $21.0M | $100.6M | $97.1M | $133.6M |